Table 5.

A brief list of HTL Epitopes to form the final structure of the vaccine

specie	epitopes	protein	antigenicity	allergenicity	IFN-γ	IL4	toxicity	epitope conservancy hit (maximum identity %)	human homology	interacting MHC-II alleles
HPyV6	VAAQRRVLMLESTRQ	LTAg	0.8394	probable non-allergen	positive	inducer	non-toxic	100	non-homologue	HLA-DRB1*04:10, HLA-DRB1*04:04, HLA-DRB1*04:05, HLA-DRB1*04:08
	GLVNLVNYAVNYNRQ	VP2	0.7212	probable non-allergen	positive	inducer	non-toxic	100	non-homologue	HLA-DRB1*08:06, HLA-DRB1*01:02, HLA-DRB1*08:13, HLA-DRB1*13:04, HLA-DRB1*08:01, HLA-DRB1*04:23
	GRFFRVHFRQRRVKH	VP1	0.4931	probable non-allergen	positive	inducer	non-toxic	100	non-homologue	HLA-DRB1*11:20, HLA-DRB1*11:14, HLA-DRB1*13:23, HLA-DRB1*08:04, HLA-DRB5*01:01, HLA-DRB5*01:05
	SAGYIRAQGTPAGVE	VP1	0.8598	probable non-allergen	positive	inducer	non-toxic	100	non-homologue	HLA-DRB1*09:01
HPyV7	DWNFVADFAADMELT	LTAg	1.2109	probable non-allergen	positive	inducer	non-toxic	100	non-homologue	HLA-DRB3*01:01, HLA-DRB1*03:09, HLA-DRB1*03:05, HLA-DRB1*04:21
	FEPGGVVMYDTQNLP	VP2	0.9125	probable non-allergen	negative	inducer	non-toxic	100	non-homologue	HLA-DRB1*15:06, HLA-DRB1*04:02, HLA-DRB1*08:06, HLA-DRB1*15:02, HLA-DRB1*08:04, HLA-DRB1*08:13, HLA-DRB1*04:10, HLA-DRB1*08:01
	FFRVHCRQRRIKHPY	VP1	0.4266	probable non-allergen	negative	inducer	non-toxic	100	non-homologue	HLA-DRB5*01:05, HLA-DRB1*11:20, HLA-DRB1*11:14, HLA-DRB1*13:23